ARCHIVES

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

September 11, 1998

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.

March 26, 2004

Combination Skin Treatments Reduce Rash From Vectibix

June 26, 2009

NCAB Urges $2 Tax On Cigarettes To Reduce Smoking

February 12, 1993